Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P.   Keating Gillian M.  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

By Garnock-Jones Karly P.   Keating Gillian M.  

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

By Stiefel Gary  

Drug Safety, Vol. 33, Iss. 10, 2010-10 ,pp. : 821-842

Adis International

Access to resources Recommend Favorite

Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder

By Bangs Mark E.   Jin Ling   Zhang Shuyu   Desaiah Durisala   Allen Albert J.   Read Holly A.   Regev Arie   Wernicke Joachim F.  

Drug Safety, Vol. 31, Iss. 4, 2008-01 ,pp. : 345-354

Adis International

Access to resources Recommend Favorite